Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Cost-effectiveness of a post-splenectomy registry for prevention of sepsis in the asplenic

Woolley I, Jones P, Spelman D, Gold L

(2006), Aust N Z J Public Health, 30(6), 558-61

Measles virus hemagglutinin protein expressed in transgenic lettuce induces neutralising antibodies in mice following mucosal vaccination

Webster DE, Smith SD, Pickering RJ, Strugnell RA, Dry IB, Wesselingh SL

(2006), Vaccine, 24(17), 3538-44

Short communication: characteristics of effective immune control of simian/human immunodeficiency virus in pigtail macaques

Stratov I, Dale CJ, Chea S, Montefiori DC, De Rose R, Reece JC, Kent SJ

(2006), AIDS Res Hum Retroviruses, 22(1), 27-32

CD4+ count-guided interruption of antiretroviral treatment

Strategies for Management of Antiretroviral Therapy (SMART) Study Group; El-Sadr WM, Lundgren JD, Neaton JD, Gordin F, Abrams D, Arduino RC, Babiker A, Burman W, Clumeck N, Cohen CJ, Cohn D, Cooper D, Darbyshire J, Emery S, Fatkenheuer G, Gazzard B, Grun*

(2006), N Engl J Med, 355(22), 2283-96

A binational cohort study of ventilator-associated pneumonia in Denmark and Australia.

Sogaard OS, Lemoh C, Spelman D, Freundlich M, Schonheyder HC, Jensen R, Watson K, Harrington G, Moller JK, Ostergaard L

(2006), Scand J Infect Dis, 38(4), 256-64

HIV infection and high-density lipoprotein: the effect of the disease vs the effect of treatment

Rose H, Woolley I, Hoy J, Dart A, Bryant B, Mijch A, Sviridov D

(2006), Metabolism, 55(1), 90-5

Fitness constraints on immune escape from HIV: Implications of envelope as a target for both HIV-specific T cells and antibody

Peut V, Kent SJ

(2006), Curr HIV Res, 4(2), 191-7

Evaluation of Subcutaneous Proleukin (interleukin-2) in a Randomized International Trial (ESPRIT): geographical and gender differences in the baseline characteristics of participants

Pett SL, Wand H, Law MG, Arduino R, Lopez JC, Knysz B, Pereira LC, Pollack S, Reiss P, Tambussi G; ESPRIT Research Group

(2006), HIV Clin Trials, 7(2), 70-85

Emergence of carbapenem resistance in Acinetobacter baumannii recovered from blood cultures in Australia

Peleg AY, Franklin C, Bell JM, Spelman DW

(2006), Infect Control Hosp Epidemiol, 27(7), 759-61

Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders

Mijch A, Burgess P, Judd F, Grech P, Komiti A, Hoy J, Lloyd JH, Gibbie T, Street A

(2006), HIV Med, 7(4), 205-12

Carriage of multiple subtypes of methicillin-resistant Staphylococcus aureus by intensive care unit patients

Lim MS, Marshall CL, Spelman D

(2006), Infect Control Hosp Epidemiol, 27(10), 1063-7

A profile of HIV testing in Victoria, 1984 to 2004

Lim MS, Guy RJ, Hellard ME

(2006), Commun Dis Intell, 30(3), 366-72

Heteroresistance to colistin in multidrug-resistant Acinetobacter baumannii

Li J, Rayner CR, Nation RL, Owen RJ, Spelman D, Tan KE, Liolios L

(2006), Antimicrob Agents Chemother, 50(9), 2946-50

HIV research in Australia: linking basic research findings with clinical and public health outcomes

Lewin SR, Kaldor JM, Cooper DA

(2006), Retrovirology, 3, 86

A randomized, placebo-controlled phase I trial of DNA prime, recombinant fowlpox virus boost prophylactic vaccine for HIV-1)

Kelleher AD, Puls RL, Bebbington M, Boyle D, Ffrench R, Kent SJ, Kippax S, Purcell DF, Thomson S, Wand H, Cooper DA, Emery S

(2006), AIDS, 20(2), 294-7

Seroepidemiology of Klebsiella pneumoniae in an Australian Tertiary Hospital and its implications for vaccine development

Jenney AW, Clements A, Farn JL, Wijburg OL, McGlinchey A, Spelman DW, Pitt TL, Kaufmann ME, Liolios L, Moloney MB, Wesselingh SL, Strugnell RA

(2006), J Clin Microbiol, 44(1), 102-7

Virological and immunological outcomes at 3 years after starting antiretroviral therapy with regimens containing non-nucleoside reverse transcriptase inhibitor, protease inhibitor, or both in INITIO: open-label randomised trial

INITIO Trial International Co-ordinating Committee; Yeni P, Cooper DA, Aboulker JP, Babiker AG, Carey D, Darbyshire JH, Floridia M, Girard PM, Goodall RL, Hooker MH, Mijch A, Meiffredy V, Salzberger B

(2006), Lancet, 368(9532), 287-98

A chlamydia prevalence survey of young women living in Melbourne, Victoria

Hocking JS, Willis J, Tabrizi S, Fairley CK, Garland SM, Hellard M

(2006), Sex Health, 3(4), 235-40

Chlamydia testing in general practice - a survey of Victorian general practitioners

Hocking JS, Lim MS, Vidanapathirana J, Read TR, Hellard M

(2006), Sex Health, 3(4), 241-4

Postal surveys of physicians gave superior response rates over telephone interviews in a randomized trial

Hocking JS, Lim MS, Read T, Hellard M

(2006), J Clin Epidemiol, 59(5), 521-4

62 63 64 65 66